SRNE
Sorrento Therapeutics Inc
Clinical and commercial stage biopharmaceutical company developing treatments for cancer, infectious disease, and pain
CUSIP: 83587F202HealthcareUS1 holder
Total Value
$118.7K
Total Shares
134.0K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Oaktree Capital Management
$118.7K134.0K sharesUnchanged